Skip to content
Clinical Trials – home
GermanyBack to Germany

Clinical trials in Bünde – page 24

618 clinical trials in Bünde, Germany. Every trial is listed in the EU Clinical Trials Register and updated daily.

GermanyOur site in GermanyKlinischeStudien.de(opens in a new tab)
Bünde at a glance
618
clinical trials
  • Research sites0
Type of trial
Recruitment status
Quick filters

618 trials in Bünde

Open in trial search

Evaluating the efficacy and safety of CRD-4730 in patients with heart failure with reduced ejection fraction

Investigational
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:CRD-4730
  • Sponsor:Cardurion Pharmaceuticals Inc.

Lung neoplasm malignant

Not yet recruiting

Feasibility Study of Fluorescence Bronchoscopy Using bevacizumab-800CW in Patients with Suspected Lung Cancer

Registered drugNo placebo
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:Bevacizumab
  • Sponsor:Universitair Medisch Centrum Groningen

Craniocerebral injury

Not yet recruiting

Safety and Efficacy of AST-004 in Patients with Mild Complicated Traumatic Brain Injury

Investigational
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:AST-004
  • Sponsor:Astrocyte Pharmaceuticals Inc.

A study of Cesnicabtagene autoleucel compared to a drug combination for patients with relapsed or refractory multiple myeloma

Registered drugNo placebo
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:Bortezomib
  • Sponsor:Universitair Medisch Centrum Groningen

Giant cell arteritis+1

Not yet recruiting

Diagnostic Accuracy of 68Ga‑FAPI‑46 PET/CT in Patients with Suspected Giant Cell Arteritis and Polymyalgia Rheumatica

InvestigationalNo placebo
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:68Ga-FAPI-46
  • Sponsor:Universitair Medisch Centrum Groningen

End stage renal disease

Not yet recruiting

A study of canagliflozin and 18F-canagliflozin in patients with chronic kidney disease undergoing dialysis

Registered drugNo placebo
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:Canagliflozin
  • Sponsor:Universitair Medisch Centrum Groningen

A Study Testing Cetuximab with Fluorescent Dye to Help Surgeons See Cancer Edges During Surgery in Patients with Oral Squamous Cell Carcinoma

Registered drugNo placebo
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:Cetuximab
  • Sponsor:Universitair Medisch Centrum Groningen

Type 1 diabetes mellitus+1

Not yet recruiting

A study testing dapagliflozin and SC0062 together compared to SC0062 alone in adults with type 1 diabetes and chronic kidney disease

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years
  • Substances:Dapagliflozin
  • Sponsor:Universitair Medisch Centrum Groningen

Acquired ATTR amyloidosis

Not yet recruiting

A Study of Acoramidis for Long-Term Safety in Patients with Newly Diagnosed Variant Transthyretin Amyloid Cardiomyopathy

InvestigationalNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Acoramidis Hydrochloride
  • Sponsor:Eidos Therapeutics Inc.

Type 2 diabetes mellitus

Not yet recruiting

Comparison of weekly insulin icodec versus daily basal insulin in adults with type 2 diabetes who have not used insulin before

Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Insulin degludec
  • Sponsor:Novo Nordisk A/S

Non-small cell lung cancer

Not yet recruiting

Study on Extending Osimertinib Dosing for Patients with EGFR Mutated Advanced Non-Small Cell Lung Cancer

Registered drugNo placebo
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:Osimertinib
  • Sponsor:Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)

Study on Imaging Head and Neck Cancer Using [18F]-Olaparib for Patients with Squamous Cell Carcinoma

InvestigationalNo placebo
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:Olaparib
  • Sponsor:Universitair Medisch Centrum Groningen

Other cities in Germany

The busiest research cities in the country

All 505 cities in Germany

Clinical research in Bünde

What the registry says about research in the country

01 Nutritional and Metabolic Diseases

The clinical trial activity in Bünde is centered on Nutritional and Metabolic Diseases, with studies focused on improving care for obesity, overweight, and type 2 diabetes. These trials are mainly testing new treatment approaches and assessing how well they support weight management and blood sugar control.

  • Weight-related treatment studies in obesity and overweight
  • Type 2 diabetes research aimed at better glycaemic control
  • Trials exploring therapy effectiveness in people with combined metabolic conditions
  • Clinical research designed to improve everyday treatment options

Several studies also connect metabolic health with other conditions, showing a broad interest in practical treatment strategies for patients in routine care.

02 Kidney Disease Research

One important area of research in Bünde involves chronic kidney disease, with trials examining whether new treatment combinations can help preserve kidney function. The goal is to evaluate treatment effectiveness and support better long-term kidney health.

  • Chronic kidney disease as a key focus of ongoing research
  • Studies assessing kidney function outcomes
  • Testing new therapeutic combinations for improved disease control

This work reflects a strong interest in finding more effective options for people living with progressive kidney problems.

03 Obesity and Weight Management

Clinical trials in the area of obesity and overweight are exploring whether new therapies can support meaningful body weight reduction. These studies are aimed at evaluating treatment benefit in people who need better options for long-term weight control.

  • Obesity and overweight as main conditions under study
  • Research focused on weight change and treatment response
  • Testing new approaches for healthier metabolic outcomes

The trials address an important area of public health by looking for more effective ways to manage excess weight.

04 Metabolic Disease and Diabetes Care

Another major theme is type 2 diabetes management, where trials are comparing treatment approaches to see how well they maintain blood sugar levels in real-world practice. The emphasis is on improving treatment effectiveness for people who already use glucose-lowering medication.

  • Type 2 diabetes treatment optimization
  • Comparisons of longer-acting and daily insulin-based options
  • Focus on sustained blood sugar control over time

These studies may help shape more practical and patient-friendly diabetes care strategies.

05 Osteoarthritis and Joint Pain

Research also includes osteoarthritis, especially knee pain linked with obesity or overweight. The trials are looking at ways to ease joint symptoms while also supporting weight-related health goals.

  • Osteoarthritis with a focus on knee pain
  • Studies involving people with obesity or overweight
  • Evaluation of symptom relief and functional improvement

This area connects musculoskeletal care with metabolic health, reflecting the close relationship between body weight and joint discomfort.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.